Endocrine Society Meets with NIH Office of Research on Women’s Health to Discuss Research Gaps & Policy Priorities

On Thursday, December 1, Janine Austin Clayton, MD, director of the NIH Office of Research on Women’s Health (ORWH) and associate director of Women’s Health Research at the NIH visited the Endocrine Society for a meeting with Endocrine Society member and associate director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Jane Reusch, MD; and the director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Judy Regensteiner, PhD.

Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society;  Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women's Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women's Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.
Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society; Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women’s Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women’s Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.

During the meeting, participants discussed research gaps and opportunities identified during the National Conference on Women’s Health Research, “Sex Differences Across the Lifespan: A Focus on Metabolism” (recently highlighted in the July Endocrine News). The group also discussed the new NIH policy on the “Consideration of Sex as a Biological Variable in NIH-funded Research.” The meeting highlighted the many synergies between the policy priorities and research interests of ORWH and the Endocrine Society.

Several specific opportunities were identified during the meeting, including working together on developing educational resources about how to appropriately consider sex as a biological variable and promoting existing resources such as the online developed by ORWH.

You may also like

  • NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

    On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1…

  • Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

    As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain. A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and…

Find more in